Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andersson GM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nyberg KA; Department of Chemistry, Environment and Feed Hygiene, National Veterinary Institute, Uppsala, Sweden.; Risk Benefit Assessment Department, National Food Agency, Uppsala, Sweden., Andersson GM; Department of Chemistry, Environment and Feed Hygiene, National Veterinary Institute, Uppsala, Sweden., Elving J; Department of Chemistry, Environment and Feed Hygiene, National Veterinary Institute, Uppsala, Sweden.
Publikováno v:
Journal of applied microbiology [J Appl Microbiol] 2019 Feb; Vol. 126 (2), pp. 651-660. Date of Electronic Publication: 2018 Nov 23.
Autor:
Geschwindner S; Discovery Sciences, AstraZeneca R&D Mölndal, 431 83 Mölndal, Sweden stefan.geschwindner@astrazeneca.com wolfgang.knecht@biol.lu.se., Andersson GM; CVMD Innovative Medicines, AstraZeneca R&D Mölndal, 431 83 Mölndal, Sweden., Beisel HG; CVMD Innovative Medicines, AstraZeneca R&D Mölndal, 431 83 Mölndal, Sweden., Breuer S; Discovery Sciences, AstraZeneca R&D Mölndal, 431 83 Mölndal, Sweden., Hallberg C; CVMD Innovative Medicines, AstraZeneca R&D Mölndal, 431 83 Mölndal, Sweden., Kihlberg BM; CVMD Innovative Medicines, AstraZeneca R&D Mölndal, 431 83 Mölndal, Sweden., Lindqvist AM; CVMD Innovative Medicines, AstraZeneca R&D Mölndal, 431 83 Mölndal, Sweden., O'Mahony G; CVMD Innovative Medicines, AstraZeneca R&D Mölndal, 431 83 Mölndal, Sweden., Plowright AT; CVMD Innovative Medicines, AstraZeneca R&D Mölndal, 431 83 Mölndal, Sweden., Raubacher F; CVMD Innovative Medicines, AstraZeneca R&D Mölndal, 431 83 Mölndal, Sweden., Knecht W; CVMD Innovative Medicines, AstraZeneca R&D Mölndal, 431 83 Mölndal, Sweden Present address: Department of Biology, Molecular Cell Biology & Lund Protein Production Platform, Lund University, 22362 Lund, Sweden stefan.geschwindner@astrazeneca.com wolfgang.knecht@biol.lu.se.
Publikováno v:
Protein engineering, design & selection : PEDS [Protein Eng Des Sel] 2015 May; Vol. 28 (5), pp. 117-25. Date of Electronic Publication: 2015 Mar 04.
Autor:
Cheshire DR; Department of Chemistry, AstraZeneca Charnwood, Bakewell Road, Loughborough LE11 5RH, United Kingdom. dave.cheshire@astrazeneca.com, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2011 Apr 15; Vol. 21 (8), pp. 2468-71. Date of Electronic Publication: 2011 Feb 18.
Publikováno v:
Nutrition and metabolism [Nutr Metab] 1979; Vol. 23 (1), pp. 26-37.
Autor:
von der Decken A, Andersson GM
Publikováno v:
The Journal of nutrition [J Nutr] 1977 Jun; Vol. 107 (6), pp. 949-58.
Autor:
Andersson GM, von der Decken A
Publikováno v:
The Biochemical journal [Biochem J] 1975 Apr; Vol. 148 (1), pp. 49-56.